INS and diabetes mellitus: Both islet transplantation and insulin treatment were effective at preventing hypergylcemia and recurrence of diabetes (Table 1 and Fig. 1A), with blood glucose control by islet transplantation superior to insulin implants (139.4±7.5 and 181.6±8.3 mg/dl respectively, P<0.05).